Oxurion NV (EBR:OXUR)

Belgium flag Belgium · Delayed Price · Currency is EUR
0.0038
-0.0002 (-5.00%)
Apr 28, 2026, 1:32 PM CET
-95.24%
Market Cap 354.77K
Revenue (ttm) 2.00K
Net Income (ttm) 1.96M
Shares Out 88.69M
EPS (ttm) 0.40
PE Ratio 0.01
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 122,000
Average Volume 584,607
Open 0.0040
Previous Close 0.0040
Day's Range 0.0038 - 0.0040
52-Week Range 0.0038 - 0.0840
Beta -0.04
RSI 36.73
Earnings Date Apr 3, 2026

About Oxurion NV

Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness in Belgium. The company is developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1991
Employees 11
Stock Exchange Euronext Brussels
Ticker Symbol OXUR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.